Vertex Pharma to Seek Speedy FDA Approval for Kidney Disease Drug From $4.9B AcquisitionNews DeskMarch 10, 20260 A Vertex Pharmaceuticals immunology drug in clinical testing for a rare kidney disease is catching up to others that work…